Fig. 1From: ImmunoPET provides a novel way to visualize the CD103+ tissue-resident memory T cell to predict the response of immune checkpoint inhibitorsIndications for current marketed immune checkpoint inhibitors, data collected from the EMA and NMPA websites until June 6th, 2023. NSCLC: Non-Small Cell Lung Cancer, MSI-H: Microsatellite Instability-high, dMMR: Mismatch repair deficientBack to article page